With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in ...
Shortly after Amgen unveiled its $1.9 billion alliance with Generate Biomedicines aimed initially at five drug molecules, Sanofi has announced a big expansion of its longstanding partnership with ...